Given the intricate involvement of Wnt/PCP in neurogenesis and the potential impact of the JNK signalling pathway on AD progression, here, we assessed whether differential expression of known Wnt regulators was associated with AD amyloid pathology and identified WNT5A, ROR and JNK components. This evidence concerns the gene WNT5A and Alzheimer disease.